Clinical Trials Browser

Phase 3 × Withdrawn × Hepatitis A Vaccines × Clear all

NCT02082639 2015-07-20

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years

Phase 3 Withdrawn

Papillomavirus Infections